A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
about
Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infectionHendra virus and Nipah virus animal vaccines.Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirusPrediction of epitope-based peptides for the utility of vaccine development from fusion and glycoprotein of nipah virus using in silico approach.Henipavirus infections: lessons from animal models.Rhabdovirus-based vaccine platforms against henipavirusesDetailed analysis of the African green monkey model of Nipah virus disease.A human lung xenograft mouse model of Nipah virus infection.A treatment for and vaccine against the deadly Hendra and Nipah virusesSingle-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo.Henipavirus pathogenesis in human respiratory epithelial cellsSingle-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.Characterization of Nipah virus infection in a model of human airway epithelial cells cultured at an air-liquid interface.Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.Serotype-specific host responses in rhesus macaques after primary dengue challenge.Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.AAV Vectors Vaccines Against Infectious Diseases.Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal DoseA recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.Henipavirus pathogenesis and antiviral approaches.Henipavirus Encephalitis: Recent Developments and Advances.Contribution of Human Lung Parenchyma and Leukocyte Influx to Oxidative Stress and Immune System-Mediated Pathology following Nipah Virus Infection.Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.Controlling Nipah virus encephalitis in Bangladesh: Policy options.Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Virology. A henipavirus vaccine in sight.Protection from Hendra virus infection with Canarypox recombinant vaccine.A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model.Altered Immunogenicity of Donor Lungs via Removal of Passenger Leukocytes Using Ex Vivo Lung Perfusion.Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains.Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species.
P2860
Q27324824-FD784BAE-3E5D-4351-8E76-EC5AB689F852Q30387821-58FE704F-CAB4-4F97-9F6C-E1C7D2AF2484Q30724121-35101897-B5D0-4724-A9C8-0B3E95CB21E2Q34039928-7B41B01C-6981-4EC9-9D95-53BCA87725CEQ34533606-ADD0BD42-8628-4CAC-9A6A-2CA4F23ADE4BQ34992537-31180E7C-28C7-4FD0-8019-AECB213920A9Q35113441-A5E3B192-D7BA-4A1A-AC5D-7A4984D5727DQ35139237-7B75034E-C140-4638-82B3-D2478F156570Q35565878-860C8D94-1EB9-44B2-A6CB-8775C26AD777Q35613127-3B16B480-1DD9-4CD3-81FC-72362E45153FQ35741723-E1B06726-E74F-451F-A432-9E17C11E3FABQ36440258-54B1ACBF-7846-453D-8EB1-F72C8CC16F72Q36667789-DB9C54D4-3A14-4699-AB50-BE146D7C92C7Q36791009-448A7DC7-27E7-4BFA-B50D-E121D4BA4DDAQ36852376-4DE15B66-7C20-4D29-93B4-9FB3A52667FDQ37147843-A9FA4EA5-6AE8-48D3-9029-62494B549F50Q37372592-92B18CB8-501E-4076-BE80-E8A76C8E5F32Q37418736-2EF11888-25CA-4DC4-981F-99A90B0B3E95Q37427047-004C881A-E6C4-40DC-863B-8953CC1AA634Q37498000-886D63F1-28DD-459E-91A7-5CF3DDE73462Q37621722-8F8CF723-0C11-4979-A832-BFEC19F8A21CQ37627029-1830C61F-1198-470F-BB54-5EF820C1878AQ37713970-82380B13-4CC9-4883-8461-A039967BAC3FQ38337204-40DD535C-1BF2-4812-AADE-E6F771FB19F2Q38567114-1FD8DF59-6207-4B39-A14B-2A1CE4CB2321Q38766458-B06D9C32-5254-4965-933B-1BBDA6E1FF0CQ39240212-1E9CDE44-6D52-4DF3-AFF4-2D0941A6D1B8Q40568826-FB8A933E-A497-4502-A127-DD4A96C7365DQ41273154-504BCF33-DE1C-400E-814A-C3F3131C34A1Q42254569-0D98D35B-E418-45B2-8778-8FD76DE3164DQ44106019-25BB379F-9BA6-46F3-8EAB-FE2F46B14EE8Q44958628-79BFA032-22E9-4377-A5C9-79DC00373839Q47105971-490F27D2-89A3-4E1C-B739-643007062D23Q47140392-BF00DA12-0A8C-4345-B0B2-3E593DC9CBDFQ50984915-B59FB774-45BD-44EA-8118-C14757F37C1DQ52726627-2BA1FC80-5319-45FF-ADC8-55051AABC07AQ53688068-7C28648D-BE63-4089-89AE-E418567C8043Q55132682-CA6BA892-9CEA-46E7-B2A8-31AC9CC8FD4E
P2860
A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@ast
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@en
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@nl
type
label
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@ast
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@en
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@nl
altLabel
A Hendra virus G glycoprotein ...... eys from Nipah virus challenge
@en
prefLabel
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@ast
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@en
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@nl
P2093
P2860
P50
P1476
A Hendra virus G glycoprotein ...... ys from Nipah virus challenge.
@en
P2093
Andrew C Hickey
Barry Rockx
Christopher C Broder
Dana Scott
Doug Brining
Joan B Geisbert
Rachel LaCasse
Yan-Ru Feng
Yee-Peng Chan
P2860
P304
P356
10.1126/SCITRANSLMED.3004241
P407
P577
2012-08-01T00:00:00Z